PTC Therapeutics
PTCT
PTCT
202 hedge funds and large institutions have $2.87B invested in PTC Therapeutics in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 69 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $2.94B → $2.87B (-$65.1M)
3% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 33
2% less funds holding
Funds holding: 206 → 202 (-4)
Holders
202
Holding in Top 10
8
Calls
$56.2M
Puts
$15.3M
Top Buyers
| 1 | +$236M | |
| 2 | +$110M | |
| 3 | +$67.8M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$53.5M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$17.6M |
Top Sellers
| 1 | -$88.6M | |
| 2 | -$58.7M | |
| 3 | -$41.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$34.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.7M |